Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up - Should You Buy?

Key Points

• Hypermarcas shares gapped up from a previous close of $4.04 to open at $4.23, with a trading volume of 361 shares.
• Scotiabank upgraded Hypermarcas to a "strong-buy" rating, suggesting positive market sentiment regarding the company's growth potential.
• The company announced a dividend payout of $0.0345, which reflects an impressive yield of 281.0% for investors of record.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) shares gapped up before the market opened on Friday . The stock had previously closed at $4.04, but opened at $4.23. Hypermarcas shares last traded at $4.23, with a volume of 361 shares.

Analysts Set New Price Targets

Separately, Scotiabank raised shares of Hypermarcas to a "strong-buy" rating in a report on Thursday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, According to MarketBeat, the stock currently has a consensus rating of "Strong Buy".

Hypermarcas Stock Up 0.4%

The company has a current ratio of 1.26, a quick ratio of 0.80 and a debt-to-equity ratio of 0.63. The stock has a market capitalization of $2.69 billion, a PE ratio of 20.22 and a beta of 0.77. The stock's fifty day simple moving average is $4.68 and its 200-day simple moving average is $4.04.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $0.12 earnings per share (EPS) for the quarter. Hypermarcas had a net margin of 11.28% and a return on equity of 6.19%.

Hypermarcas Dividend Announcement

The firm also recently announced a dividend, which will be paid on Friday, January 8th. Stockholders of record on Tuesday, July 1st will be paid a dividend of $0.0345 per share. This represents a dividend yield of 281.0%. The ex-dividend date is Monday, June 30th. Hypermarcas's payout ratio is presently 57.14%.

About Hypermarcas

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.